300832:SZSEShenzhen New Industries Biomedical Engineering Co. Ltd. Class A Analysis
Data as of 2026-09-10 - not real-time
CN¥48.18
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind Shenzhen New Industries Biomedical Engineering Co., Ltd. is neutral at ¥48.18, with no clear ordering between short and long averages. Across the trailing 30 sessions it lost 1.2%. With RSI at 42.4 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at ¥47.93 and resistance at ¥54.98.
Valuation screens as undervalued: a P/E of 22.0 sits below the sector average of 29.8. Consensus targets land 37.1% above where the shares trade now. Revenue is growing at 21.8% on a 35.7% profit margin. The 2.44% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 34.4%, a beta of 0.03 and a maximum drawdown of 43.8%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 6 out of 10.
Valuation screens as undervalued: a P/E of 22.0 sits below the sector average of 29.8. Consensus targets land 37.1% above where the shares trade now. Revenue is growing at 21.8% on a 35.7% profit margin. The 2.44% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 34.4%, a beta of 0.03 and a maximum drawdown of 43.8%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 6 out of 10.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 50.95
- MACD momentum is negative
- Maximum drawdown of 43.8%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 22.0 versus sector average of 29.8
- Trading below the 200-day average of 50.95
- Analyst targets imply +37.1% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 22.0 versus sector average of 29.8
- Analyst targets imply +37.1% versus the current price
- Profit margin of 35.7% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth21.80%
Profit Margin35.68%
P/E Ratio22.0
ROE19.87%
ROA12.99%
Debt/Equity0.04
P/B Ratio4.2
Op. Cash FlowCN¥2.0B
Free Cash FlowCN¥1.3B
Industry P/E29.8
Technical Analysis
TrendNeutral
RSI42.4
SupportCN¥47.93
ResistanceCN¥54.98
MA 20CN¥51.24
MA 50CN¥48.12
MA 200CN¥50.95
MACDBearish
VolumeDecreasing
Fear & Greed Index92.14
Valuation
Fair ValueCN¥54.27
Target PriceCN¥66.07
Upside/Downside37.12%
GradeUndervalued
TypeGrowth
Dividend Yield2.44%
Risk Assessment
Beta0.03
Volatility34.40%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.